Splicebio, S.L.
Latest round
- Series B
Last raised
- Jun 2025
Total raised
- $193M
Investors
- 10
About Splicebio, S.L.
L. develops innovative gene therapy solutions utilizing proprietary protein splicing technology, aiming to enhance the treatment of rare genetic diseases through precise and efficient genetic medicine delivery. Founded in 2012 in Barcelona, Spain, SpliceBio SL specializes in gene therapy solutions and has undergone strategic developments to focus on advancing treatments for rare diseases. The company was established by Sílvia Frutos, who has a strong background in biotechnology.L. specializes in innovative gene therapy solutions through its proprietary protein splicing technology. This core offering focuses on the precise and efficient delivery of genetic medicines, targeting therapeutic development for rare diseases. The company’s products are designed to enhance protein engineering, addressing critical medical conditions that lack effective treatments. SpliceBio’s technologies leverage the pioneering research of its founders, particularly in intein-mediated protein splicing, to create novel therapeutic modalities. Their client base primarily consists of biotechnology and pharmaceutical companies looking to advance their therapeutic pipelines, with a particular emphasis on markets in North America and Europe. This model supports SpliceBio's flagship products while enabling continuous growth and investment in research and development.
Who invested in Splicebio, S.L.
10 investors across 3 rounds
See all investors in Splicebio, S.L.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Splicebio, S.L.
Who invested in Splicebio, S.L.?
Splicebio, S.L. has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Splicebio, S.L. raised?
Splicebio, S.L. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Splicebio, S.L. last raise money?
Splicebio, S.L.'s most recent round on record is a Series B, in Jun 2025.
What does Splicebio, S.L. do?
Splicebio, S.L. is a biotechnology company.
Where is Splicebio, S.L. headquartered?
Splicebio, S.L. is headquartered in Barcelona, Spain.
Which VCs invest in companies like Splicebio, S.L.?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Splicebio, S.L.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Splicebio, S.L.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.